This High Yielder is Hard to Ignore, but It Comes with Strings Attached

Hidden Gems Revealed (Sponsored)

Triple-Digit Growth Potential Inside

The difference between a “good trade” and a wealth-building move?

Timing and precision.

Our analysts just dropped a new report: 5 Stocks Set to Double.

Inside, you’ll find:

• Companies with fundamentals built for staying power

• Technical setups flashing breakout signals

• Analyst insights you won’t find anywhere else

Past reports uncovered winners that soared +175%, +498%, even +673%.¹
This free edition expires at midnight.

[Get your copy before the window closes]

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

If your dividend radar is tuned to high yield, few names light up the screen like Altria Group, Inc. (NYSE: MO).

Trading in the mid-60s, it pays a quarterly dividend of around $1.06 per share (exceeding $4 a year) and gives a yield north of 6%.

That’s the kind of payout that can make you sit up and take notice if you’re a income-hungry investor.

The consistency of those checks is also part of the appeal. Management has made a point of keeping the dividend central to shareholder returns, with 57 consecutive years of increases. 

It is worth mentioning that while the yield looks like a feast, it does come with a side of uncertainty.

The company is wrestling with declining cigarette volumes, regulatory pressures, and the slow but necessary pivot into smoke-free products.

That said, if you can stomach the sector risks, the combination of yield and commitment to payouts makes this a tempting candidate for the bold income-focused investor.

Never Miss a Stock Recommendation Again!

We now send our dividend picks right to your phone via text, so you’ll get the same actionable moves without having to open your inbox.

👉 Click here to get our dividend picks by text and keep our content right at your fingertips.

A Cash-Flow Machine Evolving in a Changing Industry

Altria remains a cash-flow machine, built around its core U.S. tobacco business.

The company’s success is anchored by its powerhouse Marlboro brand, which commands nearly 40% of the U.S. cigarette market.

That dominance gives the company pricing power, allowing it to raise prices faster than volumes decline, and has long been the backbone of its reliable cash flow. 

Beyond smokable products, Altria has been branching into oral nicotine via on! Pouches, heated tobacco, and e-vapor through its acquisition of NJOY.

While these categories are smaller today, they’re central to the company’s future as cigarette consumption continues to fall. 

In its most recent earnings release, Altria raised its full-year guidance with adjusted EPS of $5.35 to $5.44, a growth rate of 3% to 5%.

The firm's earnings release confirmed that revenues decreased by 1.7% to $6.1 billion, primarily driven by lower net revenues in the smokeable products segment, but partially offset by higher net revenues in the oral tobacco products segment.

Management continues to emphasize shareholder returns. The dividend increased by 3.9% in August to $1.06 per share.

With a payout ratio hovering around 75%, there’s not much wiggle room, but the consistency of cash generation makes it manageable for now.

Overnight Profit Strategy (Sponsored)

From $1,200 To $30,000 — Here’s How

Most traders panic when markets plunge.

But for a select few, those days bring the biggest opportunities.

A proven “Shockwave” setup has shown the potential for overnight flips of 88%, 109%, even 157%—all by using a 15-minute trading window Wall Street overlooks.

Now, for the first time, you can see how this strategy works at the FREE Fed Shockwave LIVE Summit on Wednesday, September 24 at 2 p.m. ET.

Legendary trader Bryan Bottarelli will walk you through the exact setup—and show how everyday traders have used it to turn small stakes into eye-popping gains.

Seats are limited, and the next Shockwave could be right around the corner.

Click Here to Reserve Your FREE Spot for the Fed Shockwave Summit 

The Elephant in the Room

Altria’s biggest challenge isn’t a secret. Cigarette volumes keep falling. U.S. industry-wide shipments dropped in the mid-single digits last year, and Marlboro wasn’t immune.

The company’s playbook has long been to offset those declines with price hikes, and so far, it’s worked: revenue per pack has grown fast enough to keep the cash flowing, even as fewer packs are sold.

That pricing power is a rare advantage, but it has limits, as consumers can only absorb so much before trading down or leaving the category altogether.

That's why Altria is investing heavily in smoke-free alternatives.

The company has been pushing its own! oral nicotine pouches, which have steadily gained market share in the fast-growing pouch segment.

The $2.75 billion acquisition of NJOY Holdings in 2023 also gave Altria a direct foothold in the regulated U.S. e-vapor market, after its ill-fated Juul investment.

NJOY’s ACE device and pod system are now the cornerstone of Altria’s vaping strategy, and management has said they’ll prioritize distribution, retail partnerships, and regulatory approvals to scale it up.

At the same time, Altria has trimmed exposure to non-core bets, selling down its stake in Anheuser-Busch InBev and exiting cannabis investments to focus resources on nicotine.

The message is clear: double down on profitability in cigarettes while building a credible smoke-free portfolio that can sustain earnings when Marlboro eventually loses more ground.

So far, the transition is a slow grind. Cigarettes still account for the lion’s share of profits, and smoke-free categories aren’t yet large enough to replace them.

But Altria has shown it understands the long game: keep raising prices to extract maximum value from a shrinking base while buying time to build up new categories.

Big Money Moves (Sponsored)

Why Institutions Are Suddenly Pouring Into Crypto

Crypto history was quietly made in July — and most investors didn’t even notice.

Congress approved a landmark crypto bill by a wide margin, and the President signed it into law.

For the first time, the U.S. has a clear national framework for digital assets — ending years of uncertainty and piecemeal regulation.

This moment isn’t just political theater — it’s the beginning of the next crypto revolution.

We’ve prepared a brand-new, FREE report: “Crypto Revolution”, which shows you exactly how to position yourself for the institutional wave that’s only just beginning.

Inside, you’ll also unlock $788 in free bonus resources to sharpen your edge.

[Click here to claim your free copy + bonuses]

Regulatory clarity has finally arrived. Don’t wait until the crowd catches on.

© 2025 Boardwalk Flock LLC. All Rights Reserved. 2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States

The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.

Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.

What If This Pivot Doesn’t Pan Out?

Altria's dividend appears attractive, but it comes with a risk. The most obvious headwind is the steady erosion of the U.S. cigarette market.

Even with Marlboro's pricing power, volumes are falling faster than expected in some quarters, and there's only so much room to keep raising prices before consumers balk or switch to cheaper brands.

The company’s smoke-free transition is far from guaranteed.

Its NJOY acquisition gives Altria a second shot at e-vapor, but the market is crowded with rivals — many of which operate in regulatory gray zones.

NJOY devices are FDA-authorized, but uptake has been slower than hoped, and Altria has already had to record impairment charges.

If NJOY can’t scale, the pivot to reduced-risk products stalls.

Regulation is another wild card. The FDA continues to tighten regulations on flavored products, nicotine levels, and marketing, while state and federal governments are considering higher excise taxes.

Litigation remains a lurking threat, too, given that big tobacco has a long history of costly lawsuits that can flare up unexpectedly.

Finally, the payout ratio approaching 80% leaves little cushion.

Free cash flow is strong now, but a sharper-than-expected decline in cigarette profits, regulatory hits, or another failed investment could put the dividend under pressure.